Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce R Chong

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Psychiatry|March 6, 2025
Plasma NfL, P-tau181, and P-tau181/Aβ42 Ratio in Predicting Mild Behavioral Impairment in Dementia-Free Multiethnic Asian Older Adults With Mixed Pathology in a 5-Year Clinical CohortYingqi Liao, Joyce R Chong, Cheuk Ni Kan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2021
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advancesJoyce R Chong, Nicholas J Ashton, Thomas K Karikari, et al.
Molecular Brain|September 10, 2016
Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementiasHuayang Xing, Yun-An Lim, Joyce R Chong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 14, 2025
Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular diseaseJoyce R Chong, Saima Hilal, Boon Yeow Tan, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 5, 2025
Visit-to-visit blood pressure variability, brain MRI measures, and cognition in non-demented older adultsJiangbo Cui, Caroline Robert, An Qi Toh, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2024
Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's DiseaseLiu-Yun Wu, Joyce R Chong, Jenny P C Chong, et al.
Alzheimer'S Research & Therapy|October 4, 2024
Interactive effect of diabetes mellitus and subclinical MRI markers of cerebrovascular disease on cognitive decline and incident dementia: a memory-clinic studyJiangbo Cui, Caroline Robert, Chia May Teh, et al.
Diabetes Care|October 27, 2025
White Matter Hyperintensities Moderate the Association Between Diabetes and Non-AD Brain AtrophyJiangbo Cui, Zhaojun Liu, Wei Ying Tan, et al.
Journal of Alzheimer'S Disease : JAD|February 13, 2023
Association of Interleukin-6 and Interleukin-8 with Cognitive Decline in an Asian Memory Clinic PopulationNicole Shu Ning Teoh, Bibek Gyanwali, Mitchell K P Lai, et al.
Alzheimer'S Research & Therapy|December 13, 2023
Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer's disease and vascular dementiaXin Ying Chua, Federico Torta, Joyce R Chong, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Psychiatry|March 6, 2025
Plasma NfL, P-tau181, and P-tau181/Aβ42 Ratio in Predicting Mild Behavioral Impairment in Dementia-Free Multiethnic Asian Older Adults With Mixed Pathology in a 5-Year Clinical CohortYingqi Liao, Joyce R Chong, Cheuk Ni Kan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 12, 2021
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advancesJoyce R Chong, Nicholas J Ashton, Thomas K Karikari, et al.
Molecular Brain|September 10, 2016
Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementiasHuayang Xing, Yun-An Lim, Joyce R Chong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 14, 2025
Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular diseaseJoyce R Chong, Saima Hilal, Boon Yeow Tan, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 5, 2025
Visit-to-visit blood pressure variability, brain MRI measures, and cognition in non-demented older adultsJiangbo Cui, Caroline Robert, An Qi Toh, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2024
Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's DiseaseLiu-Yun Wu, Joyce R Chong, Jenny P C Chong, et al.
Alzheimer'S Research & Therapy|October 4, 2024
Interactive effect of diabetes mellitus and subclinical MRI markers of cerebrovascular disease on cognitive decline and incident dementia: a memory-clinic studyJiangbo Cui, Caroline Robert, Chia May Teh, et al.
Diabetes Care|October 27, 2025
White Matter Hyperintensities Moderate the Association Between Diabetes and Non-AD Brain AtrophyJiangbo Cui, Zhaojun Liu, Wei Ying Tan, et al.
Journal of Alzheimer'S Disease : JAD|February 13, 2023
Association of Interleukin-6 and Interleukin-8 with Cognitive Decline in an Asian Memory Clinic PopulationNicole Shu Ning Teoh, Bibek Gyanwali, Mitchell K P Lai, et al.
Alzheimer'S Research & Therapy|December 13, 2023
Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer's disease and vascular dementiaXin Ying Chua, Federico Torta, Joyce R Chong, et al.
Pageof 4